Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Octreotide Acetate for Injection

Approval Number

国药准字H20100099

Company武汉人福药业有限责任公司

Registration Date

September 5, 2024

Drug Information

Generic Name

注射用醋酸奥曲肽

Dosage Form

注射剂

Strength

0.1mg(按C49H66N10O10S2计)

Drug Type

化学药品

Registration Date

September 5, 2024

Company Information

Applicant Company

Company Name武汉人福药业有限责任公司

Company Address

湖北省武汉东湖新技术开发区生物园路8号

Manufacturing Company

Company Name武汉人福药业有限责任公司

Company Address

湖北省武汉东湖新技术开发区生物园路8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy